Phylogenomic evidence supporting the reclassification of Cedecea sulfonylureivorans within the genus Dryocola with subdivision into Dryocola clanedunensis subsp. clanedunensis comb. nov. and Dryocola clanedunensis subsp. sulfonylureivorans comb. nov.
International Journal of Systematic and Evolutionary Microbiology · 21.11.2025 · 75 (11)
DOI: 10.1099/ijsem.0.006977 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Systematic and Evolutionary Microbiology, erschienen am 21.11.2025. Verfasst von Taha Menasria und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Biochemistry, Faculty of Natural and Life Sciences, University of Batna 2, 05078 Batna, Algeria. Hauptthemen laut MEDLINE: Phylogeny, Enterobacteriaceae. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
The bacterial order Enterobacterales has recently undergone major taxonomic revisions, with several new families and genera described. Within this framework, the rare genus Cedecea and the newly proposed genus Dryocola occupy closely related positions. The present study provides a comprehensive phylogenomic, phenotypic and functional assessment of Cedecea sulfonylureivorans LAM2020 T and Dryocola clanedunensis H11S18 T to clarify their taxonomic relationship. Genomic relatedness indices revealed high similarity between the two type strains, with average nucleotide identity, average amino acid identity and digital DNA–DNA hybridization values exceeding established species delineation thresholds. Phylogenetic analyses based on 16S rRNA, whole genomes and core gene sets consistently placed the two strains in a robustly supported monophyletic clade. These findings were further supported by shared metabolic and phenotypic traits. Taken together, the evidence demonstrates that C. sulfonylureivorans and D. clanedunensis represent members of the same biological species. Accordingly, and in line with Rule 42 of the International Code of Nomenclature of Prokaryotes, we propose the reclassification of C. sulfonylureivorans Li et al. 2024 as a later heterotypic synonym of D. clanedunensis Maddock et al. 2023. Furthermore, we propose two subspecies within this species: D. clanedunensis subsp. clanedunensis comb. nov. and D. clanedunensis subsp. sulfonylureivorans comb. nov.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Biochemistry, Faculty of Natural and Life Sciences, University of Batna 2, 05078 Batna, Algeria.
- Department of Applied Biology, Faculty of Exact Sciences and Natural and Life Sciences, Echahid Cheikh Larbi Tebessi University, 12002 Tebessa, Algeria.
Zitieren
APA
Menasria, T., Zaatout, N., & Dekak, A. (2025). Phylogenomic evidence supporting the reclassification of Cedecea sulfonylureivorans within the genus Dryocola with subdivision into Dryocola clanedunensis subsp. clanedunensis comb. nov. and Dryocola clanedunensis subsp. sulfonylureivorans comb. nov. International Journal of Systematic and Evolutionary Microbiology, 75(11). https://doi.org/10.1099/ijsem.0.006977
Vancouver
Menasria T, Zaatout N, Dekak A. Phylogenomic evidence supporting the reclassification of Cedecea sulfonylureivorans within the genus Dryocola with subdivision into Dryocola clanedunensis subsp. clanedunensis comb. nov. and Dryocola clanedunensis subsp. sulfonylureivorans comb. nov. International Journal of Systematic and Evolutionary Microbiology. 2025;75(11). doi:10.1099/ijsem.0.006977
BibTeX
@article{Menasria2025,
author = {Menasria, Taha and Zaatout, Nawel and Dekak, Ahmed},
title = {Phylogenomic evidence supporting the reclassification of Cedecea sulfonylureivorans within the genus Dryocola with subdivision into Dryocola clanedunensis subsp. clanedunensis comb. nov. and Dryocola clanedunensis subsp. sulfonylureivorans comb. nov},
journal = {International Journal of Systematic and Evolutionary Microbiology},
year = {2025},
volume = {75},
number = {11},
doi = {10.1099/ijsem.0.006977}
}
EUVIMED